Mesoblast's Delayed Launches, Teva Split Turn Credit Suisse Bearish, page-59

  1. 844 Posts.
    lightbulb Created with Sketch.  7
    Re "It's about the dosage and delivery in particular applications"

    Ok, so what you're saying is that for all the targeted diseases the science is proven. All the company needs to nut out now is the "dosage and delivery" in each case.

    Are you able to confirm how you came by this information?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.